Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics Study of Qiliqiangxin Capsule in Healthy Subjects
ChiCTR-OPC-16008504Phase 4Recruiting
- Sponsor
- Hebei Yiling Hospital
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of qiliqiangxin in chronic heart failure (CHF), sponsored by Hebei Yiling Hospital. Primary endpoints: Cmax, Tmax and 4 more. Started Apr 2016; status: recruiting.
02
Drugs
qiliqiangxin
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on ChiCTR-OPC-16008504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-16008504.